New Treatments for Obstructive Sleep Apnea-Nat Bowditch-05/28/2013 - 8:30am

Event Information
Event Topic: 
New Treatments for Obstructive Sleep Apnea
Event Date: 
05/28/2013 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Nat Bowditch
Event Speaker Company: 
Apneon
Event Speaker Bio: 


Nat Bowditch

Nat Bowditch has worked in the medical device field, for over 25 years. Nat is the founder & CEO of OrthoHub, a software company developing software for orthopedic applications. Previously, Nat founded and served as CEO of Hancock Medical, which is developing a new therapeutic device to treat sleep apnea. In 2009-10, Nat served as Vice President of Sales and Marketing for IntraPace, which was developing gastric electrical stimulation as a treatment for obesity. As CEO of Apneon from 2006-2008, Nat managed the development and clinical testing of implantable magnets as a treatment for sleep apnea. Before entering the sleep apnea field, Nat worked for Avantec Vascular from 2001-06. The company raised $18 million to commercialize its coronary stents and balloons. Nat served as Vice President of Sales and Marketing, growing international sales to $21 million. After Avantec was sold to a Japanese company for $165 million, Nat was promoted to CEO of the US subsidiary. Nat holds degrees in biology from Cornell University and Stanford University, and an MBA from the University of Chicago.

Event Details
Cost: 
$0
Event Details: 

Obstructive sleep apnea is a growing problem. The most widely used treatment, Continuous Positive Airway Pressure (CPAP) is very effective in preventing airway blockages during sleep, but patient compliance is poor. In this presentation I will review the devices and interventions aiming to compete with CPAP, as well as innovations in CPAP that aim to improve patient compliance.